Literature DB >> 28927074

miRNA-346 promotes proliferation, migration and invasion in liver cancer.

Qiang Yu1, Xia Yang2, Weidong Duan1, Chonghui Li1, Ying Luo1, Shichun Lu1.   

Abstract

Liver cancer primarily accounts for the majority of malignancies of the liver. MicroRNAs (miRNAs) are endogenous non-coding RNAs, which are important in tumorigenesis. Abnormal expression of microRNA-346 (miR-346) has been demonstrated in various types of human cancer, however, its expression and potential molecular mechanism in liver cancer remains to be elucidated. Expression levels of miR-346 in liver cancer cell lines were determined by quantitative polymerase chain reaction. The effect of miR-346 on proliferation was evaluated by an MTT assay; cell migration and invasion were evaluated by Transwell migration and invasion assays and target protein expression was determined by western blotting. The present study observed that miR-346 was upregulated in liver cancer cell lines. miR-346 overexpression promoted cell proliferation, migration and invasion in liver cancer cells and conversely, inhibition of miR-346 resulted in the opposite effects. Furthermore, F-Box and leucine rich repeat protein (FBXL)2 was identified as a direct target of miR-346. miR-346 promoted proliferation, migration and invasion of liver cancer via FBXL2. Overall, these findings demonstrated that miR-346 may act as a potential prognostic marker and therapeutic target against liver cancer in the future.

Entities:  

Keywords:  hepatocellular carcinoma; invasion; miRNA-346; migration; proliferation

Year:  2017        PMID: 28927074      PMCID: PMC5587998          DOI: 10.3892/ol.2017.6561

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

1.  MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma.

Authors:  Bin Chen; Wenyan Pan; Xiaoxi Lin; Zhenzhen Hu; Yunbo Jin; Hui Chen; Gang Ma; Yajing Qiu; Lei Chang; Chen Hua; Yun Zou; Yang Gao; Hanru Ying; Dongze Lv
Journal:  Tumour Biol       Date:  2015-09-26

2.  miR-346 Up-regulates Argonaute 2 (AGO2) Protein Expression to Augment the Activity of Other MicroRNAs (miRNAs) and Contributes to Cervical Cancer Cell Malignancy.

Authors:  Junfei Guo; Jing Lv; Min Liu; Hua Tang
Journal:  J Biol Chem       Date:  2015-10-30       Impact factor: 5.157

3.  Determination of glutathione in apoptotic SMMC-7221 cells induced by xylitol selenite using capillary electrophoresis.

Authors:  Xue Wu; Yu Cao; Jian Zhang; Ming Lei; Xiaojie Deng; Kashif Rafiq Zahid; Yanli Liu; Ke Liu; Jihong Yang; Guomei Xiong; Hanchao Yao; Chao Qi
Journal:  Biotechnol Lett       Date:  2016-02-18       Impact factor: 2.461

4.  MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.

Authors:  Fan Yang; Long-Ji Luo; Lei Zhang; Dan-Dan Wang; Su-Jin Yang; Li Ding; Jian Li; Dan Chen; Rong Ma; Jian-Zhong Wu; Jin-Hai Tang
Journal:  Gene       Date:  2016-11-29       Impact factor: 3.688

Review 5.  Impact of genetic targets on cancer therapy: hepatocellular cancer.

Authors:  Osama Hamed; Eric T Kimchi; Mandeep Sehmbey; Niraj J Gusani; Jussuf T Kaifi; Kevin Staveley-O'Carroll
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

6.  miR-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1.

Authors:  Hong-Ling Yan; Li Li; Shu-Juan Li; Hai-Sheng Zhang; Wei Xu
Journal:  J Biochem Mol Toxicol       Date:  2016-08-08       Impact factor: 3.642

7.  F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest.

Authors:  B B Chen; J R Glasser; T A Coon; R K Mallampalli
Journal:  Oncogene       Date:  2011-10-24       Impact factor: 9.867

Review 8.  Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention.

Authors:  György Baffy
Journal:  J Clin Transl Hepatol       Date:  2013-12-15

9.  MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway.

Authors:  Cheng-Cao Sun; Shu-Jun Li; Zhan-Peng Yuan; De-Jia Li
Journal:  Aging (Albany NY)       Date:  2016-10-18       Impact factor: 5.682

10.  Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression.

Authors:  Kai-Wen Hsu; Wen-Liang Fang; Kuo-Hung Huang; Tzu-Ting Huang; Hsin-Chen Lee; Rong-Hong Hsieh; Chin-Wen Chi; Tien-Shun Yeh
Journal:  Oncotarget       Date:  2016-06-21
View more
  14 in total

1.  MicroRNA-100 functions as a tumor suppressor in cervical cancer via downregulating the SATB1 expression and regulating AKT/mTOR signaling pathway and epithelial-to-mesenchymal transition.

Authors:  Cuiping Huang; Xiaobo Qin; Na Zhao; Huijing Jin; Shuangjun Zhang; Haiyan Yang
Journal:  Oncol Lett       Date:  2020-05-29       Impact factor: 2.967

Review 2.  The Role of MicroRNAs in Hepatocellular Carcinoma.

Authors:  Xin Xu; Yuquan Tao; Liang Shan; Rui Chen; Hongyuan Jiang; Zijun Qian; Feng Cai; Lifang Ma; Yongchun Yu
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

3.  The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.

Authors:  Joanna Patrycja Wróblewska; Michał Stefan Lach; Adam Ustaszewski; Katarzyna Kulcenty; Matthew Ibbs; Inga Jagiełło; Wiktoria Maria Suchorska; Andrzej Marszałek
Journal:  Genes (Basel)       Date:  2020-03-02       Impact factor: 4.096

Review 4.  Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review.

Authors:  Kyoko Oura; Asahiro Morishita; Tsutomu Masaki
Journal:  Int J Mol Sci       Date:  2020-11-07       Impact factor: 5.923

5.  The Significance of Circular RNA DDX17 in Prostate Cancer.

Authors:  Qi Lin; Jian Cai; Qin-Quan Wang
Journal:  Biomed Res Int       Date:  2020-08-20       Impact factor: 3.411

Review 6.  MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review.

Authors:  Asahiro Morishita; Kyoko Oura; Tomoko Tadokoro; Koji Fujita; Joji Tani; Tsutomu Masaki
Journal:  Cancers (Basel)       Date:  2021-01-29       Impact factor: 6.639

7.  MicroRNA-23a/27a/24-2 cluster promotes gastric cancer cell proliferation synergistically.

Authors:  Kate Hua; Yu-Ting Chen; Chian-Feng Chen; Ya-Syuan Tang; Tzu-Ting Huang; Yu-Cheng Lin; Tien-Shun Yeh; Kuo-Hung Huang; Hsin-Chen Lee; Ming-Ta Hsu; Chin-Wen Chi; Chew-Wun Wu; Chi-Hung Lin; Yueh-Hsin Ping
Journal:  Oncol Lett       Date:  2018-06-07       Impact factor: 2.967

8.  Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.

Authors:  Weiyang Lou; Jingxing Liu; Bisha Ding; Danni Chen; Liang Xu; Jun Ding; Donghai Jiang; Lin Zhou; Shusen Zheng; Weimin Fan
Journal:  J Transl Med       Date:  2019-01-03       Impact factor: 5.531

9.  Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis.

Authors:  Agnieszka Kempinska-Podhorodecka; Malgorzata Blatkiewicz; Ewa Wunsch; Lukasz Krupa; Krzysztof Gutkowski; Piotr Milkiewicz; Malgorzata Milkiewicz
Journal:  Clin Transl Gastroenterol       Date:  2020-01       Impact factor: 4.396

10.  Influence of miR-101 on proliferation of liver cancer cells through the MAPK/ERK signaling pathway.

Authors:  Xuan Meng; Yong Shi; Xin Xiang; Chonghui Li; Xinlan Ge; Ke Pan; Yurong Liang
Journal:  Oncol Lett       Date:  2019-12-12       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.